Welcome Message
Thank you for joining us for the American Thoracic Society (ATS) Lung Disease Week, a forum designed to provide education and support for the millions of individuals living with respiratory, sleep-related, and critical care conditions. This week (November 5th-1th) is focused on Practical Aspects of Vaccination. An excellent way to provide you with up-to-date and factually correct information about vaccines.
Practical Aspects of Vaccine Development provides an academic and industry perspective on vaccine development and manufacturing. With the increasing complexity of vaccine products in development, there is a need for a comprehensive review of the current state of the industry and challenges being encountered. As one of the premiere professional societies focused on lung diseases, sleep disorders, critical care medicine and mental and physical health, To ensure vaccines benefit the global community, the ethical principles of beneficence, justice, non-maleficence, and autonomy should be examined and adhered to in the process of development, distribution, and implementation.
We are delighted you can join us for ATS Lung Disease Week "Practical Aspests of Vaccination” and invite you to participate in future ATS Lung Disease Weeks.
Donna Appell
Executive Director and Founder
Hermansky-Pudlak Syndrome
Chair, ATS Public Advisory Roundtable (PAR)
Susan Sherman
Chief Executive Officer
The LAM Foundation
Member, ATS Public Advisory Roundtable (PAR)
Vidya Krishnan, MD MHS
Professor of Medicine, Case Western Reserve University
Pulmonary, Critical Care and Sleep Medicine
CWRU/The MetroHealth System
ATS Lung Transplant Week Partners
The mission of the Hermansky-Pudlak Syndrome Network is to gather and disseminate information, to promote awareness and research, and to provide support to our members. This keeps us actively developing educational materials, pamphlets, slides, and articles to help both families and professionals understand the needs created by this syndrome. We maintain a client registry to assist with networking individuals, with each other and with medical research.
The LAM Foundation urgently seeks safe and effective treatments, and ultimately a cure, for lymphangioleiomyomatosis (LAM) through advocacy and the funding of promising research. We are dedicated to serving the scientific, medical and patient communities by offering information, resources and a worldwide network of hope and support.
